摘要
急性呼吸窘迫综合征(ARDS)是重症监护病房内常见的综合征,病死率很高。体外膜肺氧合(ECMO)是一种治疗重度ARDS的手段,尽管相关技术已经取得进步,但ECMO作为ARDS的挽救性治疗仍存在不少的争议与困惑。文章从ECMO对于重度ARDS患者存活率的影响、ECMO挽救重度ARDS患者的机制、启动ECMO治疗的时机及目标人群对ECMO治疗成功率的影响、挽救性治疗如何推进至标准化治疗以及未来ECMO在ARDS治疗中的展望做一论述。
Acute respiratory distress syndrome(ARDS)is a prevalent syndrome in ICU with a high mortality. Extracorporeal membrane oxygenation(ECMO)is one of the rescue treatments for severe ARDS. Despite advances in technology,there still are controversies and confusions about ECMO as a rescue therapy for ARDS. In this article,we will review the effect of ECMO on the survival rate of severe ARDS,the mechanism of ECMO in treating severe ARDS,the effect of optimal timing and population to initiate ECMO on the success rate of teratment,the promotion of rescue EMCO to standardized ECMO,and the future expectations of ECMO in ARDS.
作者
吴永然
杨小博
尚游
WU Yong-ran;YANG Xiao-bo;SHANG You(Department of Critical Care Medicine,Union Hospital Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430021,China)
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2022年第6期476-480,共5页
Chinese Journal of Practical Internal Medicine
基金
国家重点研发计划(2021YFC2501800)。
关键词
急性呼吸窘迫综合征
体外膜肺氧合
挽救性治疗
acute respiratory distress syndrome
extracorporeal membrane oxygenation
rescue therapy
